CAMBRIDGE, Mass.--(BUSINESS WIRE)--
Acceleron Pharma Inc. (NASDAQ:XLRN), a clinical stage biopharmaceutical
company focused on the discovery, development and commercialization of
novel protein therapeutics for cancer and rare diseases, today announced
that the company will host a conference call and live audio webcast to
report its first quarter 2014 financial results and provide a corporate
update on May 15, 2014, at 8:30 AM EDT.
To participate by teleconference, please dial 877-312-5848 (domestic) or
253-237-1155 (international) and refer to the Acceleron Q1 Earnings
Call. To access the live webcast, please select "Events & Presentations"
in the Investors & Media section on the Company's website (www.acceleronpharma.com).
To ensure a timely connection, it is recommended that users register at
least 15 minutes before the scheduled webcast.
A replay of the webcast will be archived on the Company's website and
available beginning approximately two hours after the event.
Acceleron is a clinical stage biopharmaceutical company focused on the
discovery, development and commercialization of novel protein
therapeutics for cancer and rare diseases. The company is a leader in
understanding the biology of the Transforming Growth Factor-Beta (TGF-β)
protein superfamily, a large and diverse group of molecules that are key
regulators in the growth and repair of tissues throughout the human
body, and in targeting these pathways to develop important new
medicines. Acceleron has built a highly productive R&D platform that has
generated innovative clinical and preclinical protein therapeutic
candidates with novel mechanisms of action. These protein therapeutic
candidates have the potential to significantly improve clinical outcomes
for patients with cancer and rare diseases.
For more information, please visit www.acceleronpharma.com.
Source: Acceleron Pharma